{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Lieu LB"],"funding":["National Institute of General Medical Sciences","NIGMS NIH HHS"],"pagination":["18483-18490"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11892948"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["96(46)"],"pubmed_abstract":["Antibody-drug conjugates (ADCs) represent a novel class of immunoconjugates with growing therapeutic relevance, since they combine the efficacy of cytotoxic drugs with the specificity of antibodies. However, by design, ADCs introduce structural features into the monoclonal antibody scaffold that complicate their analysis. Payload attachment to cysteine or lysine residues can often result in product heterogeneity, regarding both the number of attached drug molecules and their conjugation site, necessitating the use of state-of-the-art MS instrumentation to elucidate their complexity. In middle-down mass spectrometry (MD MS), the gas-phase sequencing of ∼25 kDa ADC subunits with different ion activation techniques generally produces rich fragmentation mass spectra; however, spectral congesti"],"journal":["Analytical chemistry"],"pubmed_title":["Enhanced Payload Localization in Antibody-Drug Conjugates Using a Middle-Down Mass Spectrometry Approach with Proton Transfer Charge Reduction."],"pmcid":["PMC11892948"],"funding_grant_id":["R35GM147397","R35 GM147397"],"pubmed_authors":["Zabrouskov V","Lieu LB","Srzentic K","Durbin KR","Mullen C","McAlister GC","Huang J","Fornelli L","Nagy C","Melani RD"],"additional_accession":[]},"is_claimable":false,"name":"Enhanced Payload Localization in Antibody-Drug Conjugates Using a Middle-Down Mass Spectrometry Approach with Proton Transfer Charge Reduction.","description":"Antibody-drug conjugates (ADCs) represent a novel class of immunoconjugates with growing therapeutic relevance, since they combine the efficacy of cytotoxic drugs with the specificity of antibodies. However, by design, ADCs introduce structural features into the monoclonal antibody scaffold that complicate their analysis. Payload attachment to cysteine or lysine residues can often result in product heterogeneity, regarding both the number of attached drug molecules and their conjugation site, necessitating the use of state-of-the-art MS instrumentation to elucidate their complexity. In middle-down mass spectrometry (MD MS), the gas-phase sequencing of ∼25 kDa ADC subunits with different ion activation techniques generally produces rich fragmentation mass spectra; however, spectral congesti","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2026-06-05T15:58:24.218Z","creation":"2026-06-05T03:06:47.194Z"},"accession":"S-EPMC11892948","cross_references":{"pubmed":["39511732"],"doi":["10.1021/acs.analchem.4c03872"]}}